Defibrillation Procedure: Shockable Rhythms, Pad Placement, Energy Selection

Procedures

Defibrillation Procedure: Shockable Rhythms, Pad Placement, Energy Selection

By gomdori, MDReviewed: August 2026Reading time: 11 min

Executive Summary

Defibrillation is the only effective therapy for ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT), which together account for approximately 25 percent of out-of-hospital cardiac arrests. Each minute of delay between collapse and shock reduces survival by 7 to 10 percent, making time-to-shock the dominant determinant of outcome. Modern biphasic defibrillators deliver 120 to 200 J (manufacturer-specific) for adults, with subsequent shocks at the same or higher energy. Pad placement is anterolateral standard (right of sternum + apex) or anteroposterior alternative for refractory cases. After rhythm assessment confirms VF or pVT, the operator charges, ensures the area is clear, and delivers a single shock with immediate resumption of CPR for 2 minutes before next pulse/rhythm check. Refractory VF — failure to convert after three shocks — affects approximately 15 percent of cases and warrants vector change to anteroposterior pad placement, escalating energy, addition of amiodarone 300 mg IV bolus, and consideration of double sequential defibrillation. Post-shock care includes targeted temperature management, urgent cardiology evaluation, and addressing the underlying H’s and T’s. Asystole and pulseless electrical activity are NOT shockable and require CPR plus epinephrine plus reversible cause search.
120-200JBiphasic Energy
75%First-Shock Success
7-10%Survival Loss/min Delay
~15%Refractory After 3 Shocks

1. Pathophysiology of Shockable Rhythms

Ventricular fibrillation (VF) is chaotic disorganized electrical activity in the ventricles producing no effective cardiac output. The myocardium is depolarizing in random small areas at varying rates, creating the characteristic ‘bag of worms’ appearance on ECG. There is no organized contraction, no cardiac output, and no pulse. Coarse VF (large amplitude, ≥3 mm) responds better to defibrillation than fine VF (smaller amplitude, ≤3 mm), which can be mistaken for asystole on a noisy monitor.

Pulseless ventricular tachycardia (pVT) is rapid wide-complex tachycardia (typically 150–250 bpm) without effective cardiac output. The mechanism — usually reentry around an ischemic or scar-related circuit — produces fast organized depolarization but at rates too high to allow ventricular filling, resulting in no measurable pulse. Unlike VF which is treated as ‘shockable rhythm,’ pVT requires both the rhythm AND the absence of pulse for shock indication; perfusing VT (with pulse) requires synchronized cardioversion or antiarrhythmic, NOT defibrillation.

The defibrillation mechanism: passing sufficient current through a critical mass of myocardium simultaneously depolarizes most of the cells, reaching a refractory state. As the refractory period ends, the SA node — the fastest natural pacemaker — captures and re-establishes organized rhythm. Modern biphasic waveforms deliver current in two phases (positive then negative or vice versa), achieving more effective depolarization at lower total energy than older monophasic waveforms.

Cardiac Conduction System Cardiac conduction system from SA node to Purkinje fibers Cardiac Conduction System SA SA Node AV AV Node HIS Bundle of His LBB Left Bundle Branch RBB Right Bundle Branch PURK Purkinje Fibers Normal pacemaker; defib resets all Backup pacemaker post-shock SA→AV: 50ms | AV delay: 100ms | His→Purkinje: 40ms | Total: ~200ms
Cardiac Conduction System

2. Rhythm Recognition: Shockable vs Non-Shockable

Shockable rhythms (VF and pVT) appear chaotic and warrant immediate defibrillation. Non-shockable rhythms (asystole and pulseless electrical activity, PEA) require continued CPR plus epinephrine plus reversible cause search; defibrillating asystole or PEA produces no benefit and wastes the minutes that determine outcome.

Asystole is the absence of detectable electrical activity on the ECG monitor. Confirm by checking lead placement, gain settings, and a second lead — fine VF can mimic asystole on certain leads. Pulseless electrical activity (PEA) is organized electrical activity (often a sinus or junctional rhythm) without a palpable pulse. PEA is treated by addressing the underlying cause (the H’s: hypovolemia, hypoxia, hydrogen ion (acidosis), hyper/hypokalemia, hypothermia; the T’s: tension pneumothorax, tamponade, toxins, thrombosis pulmonary or coronary).

An important distinction: synchronized cardioversion (used for unstable SVT, atrial fibrillation with rapid response, or perfusing VT) delivers shock synchronized to the QRS to avoid R-on-T phenomenon. Defibrillation is unsynchronized and is used only for VF and pVT. Most modern devices automatically determine whether the rhythm is shockable when in defibrillation mode.

Defibrillation — ECG Pattern ECG rhythm strip comparison: Defibrillation — ECG Pattern Defibrillation — ECG Pattern Ventricular Fibrillation (SHOCKABLE) 350 bpm Pulseless VT (SHOCKABLE) 220 bpm Asystole (NOT shockable) 0 bpm
Defibrillation — ECG Pattern

3. Pad Placement, Energy Selection, Delivery

Standard adult pad placement is anterolateral: one pad to the right of the sternum below the clavicle, one pad on the left mid-axillary line at the apex (5th-6th intercostal space). This vector passes current through the bulk of the heart. Anteroposterior placement (one pad over the precordium, one pad on the left posterior chest) is an effective alternative often used for refractory VF or for patients with cardiac devices in the standard pad zones. Pads must be at least 8 cm from any pacemaker or ICD generator.

For a hairy chest, clip rapidly with shears or apply pads forcefully to ensure good contact. For a wet chest (sweat, drowning), wipe the chest dry. For obese patients, anteroposterior placement may be preferable. For patients with transdermal medication patches in the pad zone, remove the patches first. Pediatric pads or attenuators are used for children below 8 years or under 25 kg if available; if only adult pads are available, place adult pads anteroposterior.

Modern biphasic defibrillators use 120 to 200 J for adults — the specific energy depends on manufacturer and waveform; consult the device labeling. Use the maximum dose if uncertain. Subsequent shocks should be at the same or higher energy. Older monophasic defibrillators use 360 J for all shocks. AEDs auto-select energy and prompt the operator. Pediatric energy is 2 J/kg first shock then 4 J/kg subsequent.

Delivery sequence: charge → ensure clear (visual sweep + verbal ‘I’m clear, you’re clear, oxygen clear’) → press shock → resume CPR immediately for 2 minutes before pulse/rhythm recheck. Total hands-off time should be less than 10 seconds for the rhythm/shock cycle.

ScenarioEnergyNotes
Adult biphasic120–200 J (manufacturer)Use max if uncertain
Adult monophasic (older)360 JAll shocks at 360 J
Pediatric (≥1 yr, <8 yr)2 J/kg → 4 J/kg subsequentPediatric pads if available
Refractory VF (after 3 shocks)Maximum + AP placementAdd amiodarone 300mg
Synchronized cardioversion50–200 J synced to QRSDifferent mode!
Defibrillation — Procedure Steps Surgical stepper: Defibrillation — Procedure Steps Defibrillation — Procedure Steps 1 Recognize VF/pVT 10 sec Pulse check ≤10 sec; rhythm strip confirms shockable 2 Pad placement 10 sec Anterolateral standard; AP for refractory 3 Charge 5 sec Biphasic 120-200J (manufacturer); mono 360J 4 Clear 5 sec ‘I’m clear, you’re clear, oxygen clear’ visual sweep ⚠ Verify all hands off 5 Shock + resume CPR 2 min Single shock + immediate 2-min CPR 6 Pulse / rhythm check 10 sec After 2-min CPR; max 10 sec hands-off
Defibrillation — Procedure Steps

4. Refractory VF & Advanced Strategies

Refractory VF — defined as failure to convert after three shocks at maximum biphasic energy — affects approximately 15 percent of shockable arrests and carries substantially worse prognosis than first-shock-converted cases. After three failed shocks, several strategies should be deployed in parallel rather than sequentially.

Vector change. Switch from anterolateral to anteroposterior pad placement. The current vector through the heart differs substantially between these placements, and some refractory cases convert with this change alone.

Antiarrhythmic. Amiodarone 300 mg IV/IO bolus after the third shock; additional 150 mg dose for persistent VF. Lidocaine 1–1.5 mg/kg IV bolus is an acceptable alternative if amiodarone is unavailable. Magnesium 1–2 g IV is specific for torsades de pointes (polymorphic VT with QT prolongation) but routine magnesium is not recommended for typical VF.

Reversible causes. Address the H’s and T’s actively: hypovolemia (IV fluids), hypoxia (advanced airway, FiO2 1.0), hydrogen ion (treat acidosis), hyper/hypokalemia (calcium + bicarb + insulin/dextrose for hyperK; KCl for hypoK), hypothermia (rewarming), tension pneumothorax (needle decompression), tamponade (pericardiocentesis), toxins (specific antidotes), thrombosis pulmonary (consider tPA), thrombosis coronary (cath lab if achievable).

Double sequential defibrillation (DSD). Two defibrillators with two sets of pads delivering near-simultaneous shocks. Pads from device 1 in anterolateral position, pads from device 2 in anteroposterior position. Discharge buttons pressed simultaneously. The DOSE-VF trial (2022) showed DSD improved survival to hospital discharge and good neurologic outcome compared to standard defibrillation. ECMO-CPR is considered for refractory VF in centers with capability.

Pitfall. Continuing standard anterolateral defibrillation at maximum energy without vector change or DSD beyond 5–6 shocks is unlikely to convert refractory VF. Move to anteroposterior placement after 3 failed shocks; consider DSD or ECMO-CPR for ongoing refractory VF.

5. Post-ROSC Care & Outcomes

Return of spontaneous circulation (ROSC) following defibrillation marks the start of post-cardiac-arrest care. ICU admission is mandatory. Targeted temperature management (TTM): cool to 32–36 °C × 24 hours for any comatose ROSC patient; the lower temperature was traditionally favored but more recent trials (TTM-2) suggest 36 °C is non-inferior. Hyperthermia prevention is the minimum standard. Hemodynamic optimization: MAP target 65 mmHg or higher; avoid hypotension; vasopressors as needed.

Coronary angiography: emergent for any ROSC with STEMI on post-ROSC ECG; consider for ROSC with shockable initial rhythm even without STEMI given high incidence of acute coronary occlusion. Brain protection: avoid hypoxia (SpO2 92–98%, not 100%); avoid hyperoxia; maintain normocapnia (PaCO2 35–45); avoid hyperthermia; sedate per local protocol. Neuroprognostication: defer for at least 72 hours after ROSC, longer if hypothermia used; combine clinical exam, EEG, somatosensory evoked potentials, and biomarkers.

Outcomes: out-of-hospital cardiac arrest with shockable initial rhythm has approximately 35 percent survival to discharge in modern systems with bystander CPR + early defibrillation; non-shockable rhythms have approximately 5 percent survival. In-hospital arrest survival is approximately 25 percent overall. Neurologically intact survival (CPC 1-2) approaches 80 percent of survivors when comprehensive post-arrest care is provided.

Pearl

Time-to-shock dominates outcome. Run quarterly first-30-second mock codes (recognize, get pads, place, charge, shock) — this single drill cuts time-to-shock by approximately 30 seconds in real codes and translates directly to survival.

Pitfall

Withholding a shock from a noisy monitor that ‘might be asystole’ costs more than shocking true asystole. When uncertain about VF vs asystole, shock — fine VF is commonly mistaken for asystole, and the cost of shocking asystole is essentially nothing.
Defibrillation — Risk Matrix 4×4 risk heatmap Defibrillation — Risk Matrix VF coarse VF fine pVT Asystole/PEA Initial rhythm <3 min 3-6 min 6-10 min >10 min Time to first shock 5 4 3 2 4 3 2 1 5 4 3 2 1 1 1 1 1 Very Low 2 Low 3 Moderate 4 High 5 Critical
Defibrillation — Risk Matrix
💎 PRACTICE INSIGHTS

6. Practice Insights

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)Defibrillator training time goes to energy settings and waveform arguments while pad position and hands-off time go unrehearsed, and in cardiac arrest defibrillation success is determined by what happens BEFORE the shock is delivered — early recognition, fast pad placement, minimal hands-off CPR — far more than by the energy level chosen. The button-pressing part is the easy part.

What the Guideline Misses

Guidelines give the algorithm but understate how often minutes are lost to operational issues — finding the defibrillator, peeling pads, identifying VF on a noisy monitor, awkward pad placement on a transferring patient. Quarterly mock codes built specifically around the first-30-second sequence (recognize, get pads, place, charge, shock) are the highest-yield fix; that single drill reliably shortens team time-to-shock in real codes.

Patterns That Recur

Refractory VF after 3 shocks at maximum energy is more common than guideline language suggests — approximately 15 percent of shockable arrests fall into this group. The reasonable move is anterior-posterior pad placement after the 3rd failed shock rather than waiting longer; some of these convert with the vector change alone. Double sequential defibrillation (two defibrillators, simultaneous discharge) is controversial but reasonable for true refractory VF.

Bedside Heuristic

When there is doubt about whether a rhythm is shockable, shock. Fine VF can be misread as asystole, and the cost of a shock to true asystole is essentially nothing while the cost of withholding a shock from VF is everything. The ‘shock if uncertain’ rule exists precisely because a fine-VF strip can look like asystole on a noisy monitor.

62-year-old man, witnessed cardiac arrest in ED waiting room

A man in his early 60s collapsed in the ED waiting room while waiting for a cardiology consult. CPR was initiated within 30 seconds by triage RN; AED arrived in 90 seconds; first rhythm analysis showed coarse VF. Shock 200 J biphasic, immediate CPR resumed. At 2-minute pulse check, organized rhythm present, pulse 80 — ROSC. Bedside echo showed normal LV function. He was taken urgently to cath lab, found to have 95 percent LAD occlusion, stented within 45 minutes of collapse. He was extubated POD 2, discharged POD 6 with full neurologic recovery and ICD placement.

→ Witnessed VF arrest with shock within 90 seconds and good post-arrest care produces near-normal survival. The minutes from collapse to shock are everything.

Protocol Adjustments

  • Run a quarterly first-30-second mock code (recognize, get pads, place, charge, shock) — this single drill is the most reliable way to shorten time-to-shock in real codes.
  • Switch to anterior-posterior pad placement after 3 failed shocks at maximum biphasic energy rather than waiting longer — vector change alone converts some refractory VF.
  • When a rhythm is uncertain on a noisy monitor, shock rather than withhold — the cost of shocking asystole is minimal while the cost of withholding a shock from VF is the patient.
Defibrillation Outcome Checkpoints (%) Horizontal bar chart: defibrillation outcome checkpoints (%) Defibrillation Outcome Checkpoints (%) Witnessed shockable arrests 60% First shock conversion 70% Refractory after 3 shocks 14% AP pad placement converted refractory 35% ROSC achieved (witnessed) 55% Neuro-intact survival to D/C 38%
Approximate outcome checkpoints along the defibrillation pathway; illustrative ranges, not institutional outcome data.

7. Frequently Asked Questions

What energy level should I use for adult defibrillation?
For adult biphasic defibrillators, 120 to 200 J is the standard initial dose, with the specific energy depending on the manufacturer and waveform — consult device labeling. Use the maximum biphasic dose if uncertain. Subsequent shocks should be at the same or higher energy. Older monophasic defibrillators use 360 J for all shocks. AEDs auto-select energy. For pediatric patients (1 to 8 years or under 25 kg), use 2 J/kg for the first shock and 4 J/kg for subsequent shocks. Use pediatric pads or attenuators when available; if only adult pads are available, place them anteroposterior.
What is the difference between defibrillation and synchronized cardioversion?
Defibrillation is unsynchronized — the shock is delivered as soon as the operator presses the button regardless of where in the cardiac cycle. Defibrillation is used for ventricular fibrillation and pulseless ventricular tachycardia, where there is no organized QRS to synchronize to. Synchronized cardioversion delivers the shock timed to the QRS complex (avoiding the T wave to prevent R-on-T phenomenon induction of VF). Synchronized cardioversion is used for unstable supraventricular tachycardia, atrial fibrillation with rapid ventricular response, and perfusing ventricular tachycardia. Most modern devices have a sync mode that must be enabled deliberately for cardioversion.
What should I do for refractory VF after three shocks?
Refractory VF after three shocks at maximum biphasic energy affects approximately 15 percent of shockable arrests. Strategy after three failed shocks: switch to anteroposterior pad placement (vector change alone converts some cases), give amiodarone 300 mg IV/IO bolus (additional 150 mg for persistent VF) or lidocaine 1–1.5 mg/kg as alternative, address reversible causes (the H’s and T’s), and consider double sequential defibrillation (two defibrillators, two pad sets, simultaneous discharge — DOSE-VF 2022 trial showed survival benefit). ECMO-CPR is considered for refractory VF in centers with capability.

Leave a Reply

Your email address will not be published. Required fields are marked *